Review Articles

  • cAMP-Specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling. Houslay MD, Baillie GS, Maurice DH. Circ Res. 2007 Apr 13;100(7):950-66.
  • Mechanism of tissue-selective drug action in the cardiovascular system. Barrett TD, Triggle DJ, Walker MJ, Maurice DH. Mol Interv. 2005 Apr;5(2):84-93.
  • Cyclic nucleotide phosphodiesterase-mediated integration of cGMP and cAMP signaling in cells of the cardiovascular system. Maurice DH. Front Biosci. 2005 May 1;10:1221-8.
  • Cardiovascular implications in the use of PDE5 inhibitor therapy. Maurice DH. Int J Impot Res. 2004 Jun;16 Suppl 1:S20-3
  • Dynamic regulation of cAMP signaling by cGMP in the cardiovascular system: roles of phosphodiesterase 2 and phosphodiesterase 3 enzymes. Maurice DH. Proc West Pharmacol Soc. 2003;46:32-6.
  • Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system. Maurice DH, Palmer D, Tilley DG, Dunkerley HA, Netherton SJ, Raymond DR, Elbatarny HS, Jimmo SL. Mol Pharmacol. 2003 Sep;64(3):533-46.
  • Vascular control mechanisms in penile erection: phylogeny and the inevitability of multiple and overlapping systems. Adams MA, Banting JD, Maurice DH, Morales A, Heaton JP. Int J Impot Res. 1997 Jun;9(2):85-91.